Neuphoria Therapeutics Inc.
Market Cap
$28.52M
P/E Ratio
-7.67
EPS
$-0.69
Dividend Yield
0.00%
52-Week Range
$3.65 — $21.40
Volume
2.53K
Avg Volume
47.42K
Beta
0.48
Get alerted when NEUP hits your target price.
Free — enter your email to get started
P/E (TTM)
-7.67
Forward P/E
—
PEG Ratio
-0.01
P/S (TTM)
3.13
P/B (TTM)
0.73
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-15.38%
ROA (TTM)
-10.20%
ROIC
—
Gross Margin
0.96%
Operating Margin
-137.14%
Net Margin
—
Debt/Equity
0.00
Current Ratio
9.04
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.40%
EPS Growth (5Y)
-0.28%
Sales Growth (3Y)
-0.33%
Sales Growth (5Y)
-0.40%
EPS Est (This Year)
$-4.07
EPS Est (Next Year)
$-2.43
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$4.89
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
1.86M
Float
1.71M
Free Float %
91.91%
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
US
Exchange
NASDAQ
IPO Date
2021-12-16
Employees
8
CEO
Spyridon Papapetropoulos
Index Membership
—
Website
http://www.neuphoriatx.com
Neuphoria Therapeutics Inc. (NEUP) is a healthcare company in the medical - pharmaceuticals industry listed on the NASDAQ. With a market capitalization of $28.52M, a P/E ratio of -7.67, NEUP is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare NEUP against other stocks using dozens of fundamental and technical filters.
Neuphoria Therapeutics Inc. (NEUP) has a trailing twelve-month (TTM) P/E ratio of -7.67. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Neuphoria Therapeutics Inc. (NEUP) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Neuphoria Therapeutics Inc. (NEUP) has a market capitalization of $28.52 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.